These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 7937785

  • 1. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
    Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9436-40. PubMed ID: 7937785
    [Abstract] [Full Text] [Related]

  • 2. Administration of AGEs in vivo induces extracellular matrix gene expression.
    Striker LJ, Striker GE.
    Nephrol Dial Transplant; 1996 Sep 27; 11 Suppl 5():62-5. PubMed ID: 9044310
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U.
    Diabetes; 1997 Nov 27; 46(11):1881-7. PubMed ID: 9356040
    [Abstract] [Full Text] [Related]

  • 4. Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis.
    Yang CW, Vlassara H, Striker GE, Striker LJ.
    Kidney Int Suppl; 1995 Jun 27; 49():S55-8. PubMed ID: 7674596
    [Abstract] [Full Text] [Related]

  • 5. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH.
    Nutrients; 2018 Jul 09; 10(7):. PubMed ID: 29987200
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    Pereira-Simon S, Rubio GA, Xia X, Cai W, Choi R, Striker GE, Elliot SJ.
    PLoS One; 2016 Jul 09; 11(7):e0159666. PubMed ID: 27428057
    [Abstract] [Full Text] [Related]

  • 7. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli.
    Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H.
    Diabetes; 1995 Aug 09; 44(8):895-9. PubMed ID: 7621993
    [Abstract] [Full Text] [Related]

  • 8. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.
    J Diabetes; 2015 Jan 09; 7(1):114-24. PubMed ID: 24666836
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice.
    Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot S, Striker GE, Striker LJ.
    J Am Soc Nephrol; 1995 Feb 09; 5(8):1610-7. PubMed ID: 7538809
    [Abstract] [Full Text] [Related]

  • 10. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS, Jung DH, Lee IS, Pyun BJ, Kim JS.
    Phytomedicine; 2016 Apr 15; 23(4):388-97. PubMed ID: 27002409
    [Abstract] [Full Text] [Related]

  • 11. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN, LaPage J, Hirschberg R.
    Kidney Int; 2000 Mar 15; 57(3):1002-14. PubMed ID: 10720953
    [Abstract] [Full Text] [Related]

  • 12. Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.
    Ohashi S, Abe H, Takahashi T, Yamamoto Y, Takeuchi M, Arai H, Nagata K, Kita T, Okamoto H, Yamamoto H, Doi T.
    J Biol Chem; 2004 May 07; 279(19):19816-23. PubMed ID: 15004023
    [Abstract] [Full Text] [Related]

  • 13. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M, Bondeva T, Franke S, Hause S, Wolf G.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):641-653. PubMed ID: 27638909
    [Abstract] [Full Text] [Related]

  • 14. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B, Qiang G, Zhao Y, Yang X, Chen X, Yan Y, Wang X, Liu C, Zhang L, Du G.
    Cell Physiol Biochem; 2017 Apr 01; 44(6):2378-2394. PubMed ID: 29262395
    [Abstract] [Full Text] [Related]

  • 15. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.
    Kidney Int; 2005 Oct 01; 68(4):1583-9. PubMed ID: 16164635
    [Abstract] [Full Text] [Related]

  • 16. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy.
    Sakai H, Jinde K, Suzuki D, Yagame M, Nomoto Y.
    Nephrol Dial Transplant; 1996 Oct 01; 11 Suppl 5():66-71. PubMed ID: 9044311
    [Abstract] [Full Text] [Related]

  • 17. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.
    Pugliese G, Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, Lenti L, Sale P, Gradini R, Liu FT, Di Mario U.
    Diabetes; 2000 Jul 01; 49(7):1249-57. PubMed ID: 10909985
    [Abstract] [Full Text] [Related]

  • 18. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K, Huang J, Xie X, Wang S, Chen C, Shen X, Liu P, Huang H.
    Free Radic Biol Med; 2013 Dec 01; 65():528-540. PubMed ID: 23891678
    [Abstract] [Full Text] [Related]

  • 19. Chronic advanced-glycation end products treatment induces TXNIP expression and epigenetic changes in glomerular podocytes in vivo and in vitro.
    Thieme K, Pereira BMV, da Silva KS, Fabre NT, Catanozi S, Passarelli M, Correa-Giannella ML.
    Life Sci; 2021 Apr 01; 270():118997. PubMed ID: 33453249
    [Abstract] [Full Text] [Related]

  • 20. Mitofusin 2 attenuates the histone acetylation at collagen IV promoter in diabetic nephropathy.
    Mi X, Tang W, Chen X, Liu F, Tang X.
    J Mol Endocrinol; 2016 Nov 01; 57(4):233-249. PubMed ID: 27997345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.